Mode
Text Size
Log in / Sign up

Retrospective cohort examines pre-amputation vascular workup phenotypes in chronic limb-threatening ischemia patients

Retrospective cohort examines pre-amputation vascular workup phenotypes in chronic limb-threatening …
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider variation in pre-amputation vascular workup phenotypes associated with mortality and cost differences in CLTI patients.

This retrospective cohort study evaluated 10,666 Medicare fee-for-service beneficiaries aged 66 years with chronic limb-threatening ischemia undergoing incident major lower-extremity amputation. Patients were categorized into four pre-amputation vascular workup pathway phenotypes based on specialist consultation, imaging, and revascularization attempts. Follow-up included 12 months continuous enrollment and 1-year post-amputation.

Phenotype A, involving no specialist, imaging, or revascularization, comprised 9.4% of the cohort. Phenotype D, where revascularization was attempted, accounted for 32.7%. Phenotype A was associated with 40% 1-year mortality compared to 51% in Phenotype D. Adjusted costs at 180 days were 50% lower in Phenotype A.

Phenotype A had lower 90-day readmissions with an odds ratio of 0.54 (95% CI, 0.47-0.64). Predictors for Phenotype A included dementia (OR 2.0; 95% CI, 1.61-2.52), paralysis (OR 4.1; 95% CI, 2.62-6.34), and dual eligibility (OR 1.2; 95% CI, 1.01-1.42). Higher comorbidity burden was inversely associated with Phenotype A (OR 0.49 for >6 vs 0-3 Elixhauser comorbidities).

The study relied on claims-based classification and retrospective design. Hospital-level variation in Phenotype A ranged from 3% in Boston and Atlanta to 16% in Little Rock. System-level interventions could address gaps in vascular evaluation before amputation. Results were robust to acuity adjustment, exclusion of early deaths, and propensity-score matching.

Study Details

Study typeCohort
Sample sizen = 824
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background. Guidelines recommend vascular specialist evaluation and revascularization consideration before major amputation in chronic limb-threatening ischemia (CLTI). Whether patients consistently receive pre-amputation vascular workup is poorly characterized nationally. Methods. We conducted a retrospective cohort study of Medicare fee-for-service beneficiaries 66 years with CLTI undergoing incident major lower-extremity amputation (2021-2022) with 12 months continuous enrollment. Using claims in the 180 days preceding hospitalization for amputation, we classified patients into mutually exclusive pathway phenotypes: (A) no specialist, no imaging, no revascularization attempt; (B) specialist only, no revascularization attempt; (C) imaging, no revascularization attempt; or (D) revascularization attempted. Mixed-effects multinomial regression with hospital random intercepts identified predictors of phenotype membership. Post-amputation outcomes were compared across phenotypes. Results. Among 10,666 patients (mean age 76.6 years; 35% female; 70% White, 21% Black), phenotype distribution was: A, 9.4%; B, 7.1%; C, 50.7%; D, 32.7%. Thus, 16.6% had no vascular imaging before amputation. Dementia (OR 2.0; 95% CI, 1.61-2.52), paralysis (OR 4.1; 2.62-6.34), and dual eligibility (OR 1.2; 1.01-1.42) were independently associated with phenotype A. Higher comorbidity burden was inversely associated with A (OR 0.49 for >6 vs 0-3 Elixhauser comorbidities). Phenotype A patients had lower 1-year mortality (40% vs 51% for D), fewer readmissions (90-day OR 0.54; 0.47-0.64), and lower costs (adjusted 50% lower at 180 days). Results were robust to acuity adjustment, exclusion of early deaths, and propensity-score matching (n=824 pairs). Phenotype A prevalence varied widely across hospital referral regions, ranging from 3% (Boston, Atlanta) to 16% (Little Rock) among regions with >100 patients. Conclusions. One in six CLTI amputees had no vascular imaging before amputation. Patients without evaluation were characterized by cognitive impairment, functional limitation, lower healthcare engagement, and socioeconomic disadvantage rather than extreme medical complexity. Hospital-level variation suggests system-level interventions could address these gaps.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.